Bristol Myers Squibb (NYSE: BMY) reported its third quarter 2024 earnings results today. Total revenues increased 8% year-over-year to $11.9 billion. Revenues
Search Results for: BB
Earnings Summary: Highlights of Royal Caribbean’s (RCL) Q3 2024 report
Cruise line operator Royal Caribbean Group (NYSE: RCL) Tuesday reported higher revenue and adjusted earnings for the third quarter of 2024. Q3
Abbott Laboratories (ABT) Q3 2024 Earnings: Key financials and quarterly highlights
Abbott Laboratories (NYSE: ABT) reported third quarter 2024 earnings results today. Total reported sales increased 4.9% year-over-year to $10.6 billion. Organic sales
BB Earnings: Highlights of BlackBerry’s Q2 2025 financial results
BlackBerry Limited (NYSE: BB) has announced financial results for the second quarter of 2025, reporting an increase in revenues. On an adjusted
BBY Earnings: Best Buy Q2 2025 profit rises despite lower revenues
Consumer electronics retailer Best Buy Co., Inc. (NYSE: BBY) on Thursday reported an increase in earnings for the second quarter of 2025,
BMY Earnings: Bristol-Myers Squibb reports higher Q2 revenue and profit
Biotechnology company Bristol Myers Squibb (NYSE: BMY) Friday reported higher revenues and net profit for the second quarter of 2024. Net income
AbbVie Q2 2024 adj. profit drops despite higher revenues; results beat
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Thursday announced second-quarter 2024 financial results, reporting a decline in adjusted earnings and an increase
Abbott Laboratories (ABT) Q2 2024 Earnings: Key financials and quarterly highlights
Abbott Laboratories (NYSE: ABT) reported second quarter 2024 earnings results today. Net sales increased 4% year-over-year to $10.4 billion. Net earnings decreased
BB Earnings: BlackBerry reports loss for Q1 2025; revenue falls
BlackBerry Limited (NYSE: BB) has reported a net loss for the first quarter of 2025, on an adjusted basis. The bottom line
Best Buy Co. (BBY) Q1 2025 earnings rise; comparable sales down 6.1%
Best Buy Co., Inc. (NYSE: BBY), a leading retailer of consumer electronics and related merchandise, reported higher profit for the first quarter
Highlights of AbbVie’s Q1 2024 financial results
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest
Key highlights from Bristol Myers Squibb’s (BMY) Q1 2024 earnings results
Bristol Myers Squibb (NYSE: BMY) reported first quarter 2024 earnings results today. Total revenues increased 5% year-over-year to $11.9 billion. When adjusted
Key highlights from Abbott Laboratories (ABT) Q1 2024 earnings results
Abbott Laboratories (NYSE: ABT) reported its first quarter 2024 earnings results today. Total sales increased 2.2% year-over-year to $10 billion. Organic sales growth
Best Buy Co. (BBY) Q4 2024 Earnings: Key financials and quarterly highlights
Best Buy Co., Inc. (NYSE: BBY) reported its fourth quarter 2024 earnings results today. Revenues totaled $14.6 billion compared to $14.7 billion
Infographic: How Bristol Myers Squibb (BMY) performed in Q4 2023 financial results
Bristol Myers Squibb (NYSE: BMY) reported fourth quarter 2023 earnings results today. Total revenues inched up 1% to $11.5 billion versus the
ABBV Earnings: Everything you need to know about AbbVie’s Q4 report
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced fourth-quarter 2023 financial results, reporting lower revenues and net income. The company reported
Infographic: Highlights of Abbott Laboratories’ (ABT) Q4 2023 earnings report
Abbott Laboratories (NYSE: ABT), a diversified healthcare services company, Wednesday reported its fourth quarter 2023 financial results. Net income, excluding special items, increased
Best Buy (BBY) Q3 2024 Earnings: Key financials and quarterly highlights
Best Buy Co., Inc. (NYSE: BBY) reported its earnings results for the third quarter of 2024 today. Enterprise revenue totaled $9.7 billion
BMY Earnings: Highlights of Bristol-Myers Squibb’s Q3 2023 results
Biotechnology company Bristol Myers Squibb (NYSE: BMY) Friday reported mixed results for the third quarter of 2023. The company also provided guidance
ABBV Earnings: A snapshot of AbbVie’s Q3 2023 report
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced third-quarter 2023 financial results, reporting lower revenues and net income. The company reported
Infographic: Key highlights from Abbott Laboratories’ (ABT) Q3 2023 earnings results
Abbott Laboratories (NYSE: ABT) reported third quarter 2023 earnings results today. Net sales decreased 2.6% year-over-year to $10.1 billion. On an organic basis,